The diagnostic value of exosomal circular RNAs in cancer patients: A systematic review and meta‐analysis

Abstract Background Recently, serum exosomal circular RNAs (circRNAs) were applied to discriminate cancer patients from healthy individuals, indicating that exosomal circRNAs have the potential to be novel biomarkers for cancer diagnosis. This study aims to summarize the role of exosomal circRNAs in cancer diagnosis by a meta‐analysis. Methods A comprehensive literature search was conducted up to July 2021 in PubMed, Web of Science, EMBASE, and Cochrane Database. To evaluate the diagnostic value, the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the curve (AUC) were pooled. Threshold effect followed by subgroup analysis and meta‐regression were performed to explore the source of heterogeneity. Sensitivity analysis was performed to assess the stability of this meta‐analysis model. Fagan plots and likelihood ratio scattergrams were used to explore the potential clinical significance. Results Ten eligible studies with 514 controls and 557 patients were included in this diagnostic meta‐analysis. The pooled sensitivity, specificity, PLR, NLR, and DOR were 0.75 (95% CI: 0.65–0.83), 0.84 (95% CI, 0.78–0.89), 5.87 (95% CI, 3.67–9.38), 0.28 (95% CI, 0.19–0.40), and 21.15 (95% CI, 10.25–43.68), respectively. The AUC was 0.89 (95% CI, 0.86–0.91). Sensitivity analysis showed that four studies had an impact on the pooled results and mainly contributed to the heterogeneity. Fagan's nomogram revealed that the prior probability of 20%, the post probability positive, the post probability negative were 59% and 6%, respectively. Conclusion Our results suggested that exosomal circRNAs might serve as powerful biomarkers in detecting cancers with high sensitivity and specificity. However, more well‐designed and multicenter diagnostic tests are needed to validate our results.